美国根据《降低通货膨胀法》规定2027年经谈判达成的药品价格,削减了医疗药品的费用。 The U.S. set negotiated drug prices for 2027 under the Inflation Reduction Act, cutting costs for Medicare drugs.

美国公布了2027年经谈判达成的药物价格,这是执行《降低通货膨胀法》的一个关键步骤。 The U.S. has released negotiated drug prices for 2027, marking a key step in the implementation of the Inflation Reduction Act. 清单包括大幅降低价格的主要药品,目的是降低医疗保险受益人的费用。 The list includes major medications with significant price reductions, aiming to lower costs for Medicare beneficiaries. 最后的价格反映了政府与制药公司之间的谈判,一些销售量最高的药品被大幅度削减。 The final prices reflect negotiations between the government and pharmaceutical companies, with some top-selling drugs seeing substantial cuts. 预计这一举措将影响到全国各地的处方成本和药物价格。 The move is expected to impact prescription costs and drug affordability across the country.